Issue Date: July 5, 2010
Losing Patent Fights In India
India’s patent office ruled in April that the patent on Valcyte, a Roche drug that prevents infection in transplant patients, is not valid in the country. With its decision, the patent office endorsed claims by Indian generic drug companies that Valcyte is not sufficiently innovative.
The Roche case is just the latest in a growing list of instances in which international drug companies are unable to secure protection in India for patented drugs they sell . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society